Delivery of compositions comprising circular polyribonucleotides
US-2023104113-A1 · Apr 6, 2023 · US
US12410432B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12410432-B2 |
| Application number | US-202117236600-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 21, 2021 |
| Priority date | Apr 21, 2021 |
| Publication date | Sep 9, 2025 |
| Grant date | Sep 9, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of cyclizing an L-RNA aptamer by modifying the aptamer with a 3′ azide and a 5′ alkyne group and using click chemistry reaction-based method. The cyclized L-RNA aptamers have improved binding properties and favour more in vitro/cell applications. Also disclosed is an L-oligonucleotide aptamer having linked ends.
Opening claim text (preview).
What is claimed is: 1. A method of linking two terminal ends of oligonucleotide, wherein one of the terminal oligonucleotide ends has a 5′ terminal alkyne; and the other one of the terminal oligonucleotide ends has a 3′ azide residue; comprising the step of: linking the 5′ terminal alkyne to the 3′ azide residue, wherein the oligonucleotide is L-Apt.4-1c comprising the nucleotide sequence of SEQ ID NO: 1. 2. A method of joining two terminal ends of an oligonucleotide as claimed in claim 1 , wherein the step of linking the 5′ terminal alkyne to the 3′ azide residue is carried out in the presence of a catalyst for azide-alkyne cycloaddition. 3. A method of joining two terminal ends of an oligonucleotide as claimed in claim 2 , wherein the catalyst is Cu(I). 4. A method of joining two terminal ends of an oligonucleotide as claimed in claim 3 , wherein the step of providing a catalyst for azide-alkyne cycloaddition comprises: providing Cu in a higher oxidation state; and a reducing agent to reduce the Cu in a higher oxidation state to Cu(I). 5. A method of joining two terminal ends of an oligonucleotide as claimed in claim 4 , wherein the Cu is provided in the form of copper (II) complex with the ligand tris(benzyltriazolylmethyl)amine. 6. A method of joining two terminal ends of an oligonucleotide as claimed in claim 4 , wherein the reducing agent is ascorbic acid or its salt. 7. A method of joining two terminal ends of an oligonucleotide as claimed in claim 4 , wherein the Cu in a higher oxidation state is Cu(II)-TBTA.
Aptamers · CPC title
having two phosphorus atoms as ring hetero atoms in the same ring · CPC title
Five-membered rings · CPC title
Closed or circular · CPC title
Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.